Step by Step

INTRODUCTION

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.25

Target Audience:

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Review the treatment of hyperbilirubinemia in the newborn 35 weeks or more.. 
  • Review the definition of Kernicterus
  • Review the management and when to escalate care in infants more than 35 weeks old who have hyperbilirubinemia.

There is no educational content to this course. This course is designed to only administer the post-test and collect CME evaluations for the podcast associated with this training.

A Note From Dr. Tarchichi:
This series of podcasts were created to keep the busy physician of today informed and up to date on some of the most important diagnoses and issues we face every day in the care of hospitalized children. Please log in, complete a brief quiz, a course evaluation and get your CME credit. Thank you for listening and enjoy.

Educational content can be found on Apple Podcasts: PHM from Pittsburgh: Hyperbilirubinemia in the newborn 35 weeks or more – Updated Guidelines! on Apple Podcasts

Suggested Additional Reading & Joint Accreditation Statement - Note: This Accreditation Statement Supersedes All Other Statements:

Suggested Additional Reading:

Alex R. Kemper, Thomas B. Newman, Jonathan L. Slaughter, M. Jeffrey Maisels, Jon F. Watchko, Stephen M. Downs, Randall W. Grout, David G. Bundy, Ann R. Stark, Debra L. Bogen, Alison Volpe Holmes, Lori B. Feldman-Winter, Vinod K. Bhutani, Steven R. Brown, Gabriela M. Maradiaga Panayotti, Kymika Okechukwu, Peter D. Rappo, Terri L. Russell; Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics August 2022; 150 (3): e2022058859. 10.1542/peds.2022-058859


Joint Accreditation Statement: 

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.


Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Authors:
Alison V. Holmes, MD, MPH, MS — Associate Professor of Pediatrics, Associate Dean for Student Affairs, Dartmouth School of Medicine
No relationships with industry relevant to the content of this educational activity have been disclosed.
Maha Kaissi, MD — Assistant Professor of Pediatrics, School of Medicine Department of Pediatrics, University of Pittsburgh
No relationships with industry relevant to the content of this educational activity have been disclosed.
Tony R. Tarchichi MD — Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Diagnostic Referral Group
No relationships with industry relevant to the content of this educational activity have been disclosed.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

The University of Pittsburgh is an affirmative action, equal opportunity institution.